Home Leading Minds Podcast Winning for Cancer Patients with Purpose and Perseverance

    Winning for Cancer Patients with Purpose and Perseverance Cover Image

    Episode 9: Winning for Cancer Patients with Purpose and Perseverance

    Join us for an insightful discussion with Michael Bailey, CEO of AVEO Oncology. Michael and Jasmeet delve into the realities of career growth, exploring both the triumphs and setbacks. Michael, a strong advocate for active listening, shares how this skill empowers leaders. He'll discuss the common pitfalls of aspiring leaders feeling pressure to climb the ladder quickly, which leads to taking shortcuts or neglecting a solid foundation, ultimately hindering long-term success. Michael also introduces his concept of the five E's of life and career. Don't miss this valuable episode packed with leadership insights!

    In This Episode, We Cover:

    • [3:02] Michael provides an overview of his professional journey
    • [6:30] Michael outlines some setbacks and failures he has experienced
    • [11:29] Discussion on mergers and acquisitions
    • [15:21] Michael describes the goals he has for the company and the importance of being reputable
    • [19:35] Michael discusses the future he sees in biotech and the value of mentors
    • [26:10] Michael gives advice to up-and-coming leaders and describes how he continues to learn
    • [29:50] Michael shares how he balances his personal and professional lives
    • [33:11] Jasmeet asks Michael rapid-fire questions

    Key Takeaways:

    • [7:53] The FDA is in place to bring patients the best and safest therapies. It’s essential to listen to them when conducting and designing studies. 
    • [11:14] During an acquisition, it must be a strategic fit. There should be a common goal and mission.
    • [16:45] Your company's reputation is essential to establish it in the marketplace for long-term success. 

    About Speaker

    Meet Michael P. Bailey:

    Michael P. Bailey serves as president and chief executive officer for AVEO Oncology (an LG Chem company) and is a member of AVEO’s board of directors. Michael brings more than 30 years of experience in the pharmaceutical industry to the company. Before LG Chem acquired AVEO in January of 2023, Mr. Bailey was named president and chief executive officer of AVEO Oncology in January 2015. Before that appointment, Mr. Bailey served as AVEO’s chief business officer from 2013 to 2015 and its chief commercial officer from 2010 to 2013. Mr. Bailey joined AVEO from Synta (now Madrigal Pharmaceuticals), serving as senior vice president, business development, and chief commercial officer since 2008. Before joining Synta, Mr. Bailey led ImClone Systems’ (now Eli Lilly) Worldwide Commercial Organization. During his nine-year tenure at ImClone Systems, he was responsible for commercial aspects of the planning and launch of ERBITUX® (cetuximab) across multiple oncology indications, as well as new product planning for the ImClone Systems development portfolio, which included CYRAMZA® (ramucirumab) and necitumumab. In addition, Mr. Bailey was a key member of the strategic leadership committees for ImClone and its North American and worldwide partnerships. Before joining ImClone Systems, Mr. Bailey managed the cardiovascular development portfolio at Genentech, Inc., and was a key member of their global commercial partnership teams. Mr. Bailey started his career in the pharmaceutical industry as part of SmithKline Beecham’s Executive MBA Marketing Development Program, where he held various commercial roles, including sales, strategic planning, and product management. Mr. Bailey received a B.S. in psychology from St. Lawrence University and an M.B.A. in international marketing from the Mendoza College of Business at the University of Notre Dame.


    Speak To Our Expert

    Leading Minds Podcast

    The Leading Minds podcast by Axtria, in partnership with Life Sciences Voice delves deep inside the minds of the top life sciences executives, including pharmaceuticals, biotech, medical devices, consumer health, animal health, and leaders from related industries. In every episode, we meet a leader who has made a lasting impact in the life sciences industry and continues to drive the industry forward.